Adi Haber

615 total citations
33 papers, 404 citations indexed

About

Adi Haber is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Adi Haber has authored 33 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Biotechnology. Recurrent topics in Adi Haber's work include Metal-Catalyzed Oxygenation Mechanisms (4 papers), Porphyrin and Phthalocyanine Chemistry (4 papers) and PARP inhibition in cancer therapy (4 papers). Adi Haber is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (4 papers), Porphyrin and Phthalocyanine Chemistry (4 papers) and PARP inhibition in cancer therapy (4 papers). Adi Haber collaborates with scholars based in Israel, United States and Belgium. Adi Haber's co-authors include Zeev Gross, Michael Aviram, Atif Mahammed, Nina Volkova, Bianca Fuhrman, Raymond Coleman, Tony Hayek, Lali K. Medina‐Kauwe, Hasmik Agadjanian and Itzchak Angel and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Adi Haber

22 papers receiving 399 citations

Peers

Adi Haber
Andrew J. Lampkins United States
Lei Hu China
Chenxi Wang China
Carmelo Drago Italy
Peter J. Choi New Zealand
Vu Le United States
Gayathri Ratnaswamy United States
Caterina Bernini Italy
Xueyan Zhen China
Nobuyuki Fukui Japan
Andrew J. Lampkins United States
Adi Haber
Citations per year, relative to Adi Haber Adi Haber (= 1×) peers Andrew J. Lampkins

Countries citing papers authored by Adi Haber

Since Specialization
Citations

This map shows the geographic impact of Adi Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Haber more than expected).

Fields of papers citing papers by Adi Haber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Haber. The network helps show where Adi Haber may publish in the future.

Co-authorship network of co-authors of Adi Haber

This figure shows the co-authorship network connecting the top 25 collaborators of Adi Haber. A scholar is included among the top collaborators of Adi Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi Haber. Adi Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lavy-Shahaf, Gitit, Roni Blatt, Itai Tzchori, et al.. (2025). Testing the effects of topical skin care products on Tumor Treating Fields (TTFields) adhesiveness of arrays and delivery of electric currents. Supportive Care in Cancer. 33(11). 1008–1008.
2.
Ladner, Katherine J., Xianda Zhao, Roni Blatt, et al.. (2025). Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo system. STAR Protocols. 6(1). 103535–103535. 1 indexed citations
3.
Haber, Adi, et al.. (2025). Effects of tumor treating fields (TTFields) with FOLFIRINOX on BRCA WT pancreatic cancer cells.. Journal of Clinical Oncology. 43(4_suppl). 753–753.
4.
Ben‐Meir, Kerem, Adi Haber, Ignace Vergote, et al.. (2024). Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance. Frontiers in Oncology. 14. 1402851–1402851. 3 indexed citations
5.
Voloshin, Tali, Lilach Koren, Yaara Porat, et al.. (2024). Abstract 4762: Tumor treating fields (TTFields) increase cancer cell membrane permeability and improve sensitivity to doxorubicin in vitro and in vivo. Cancer Research. 84(6_Supplement). 4762–4762. 3 indexed citations
6.
7.
8.
9.
Friedman, Sivan, Adi Haber, Nurit Livnat‐Levanon, et al.. (2022). Listeria monocytogenes TcyKLMN Cystine/Cysteine Transporter Facilitates Glutathione Synthesis and Virulence Gene Expression. mBio. 13(3). e0044822–e0044822. 11 indexed citations
10.
11.
Shteingauz, Anna, Catherine Tempel-Brami, Einav Zeevi, et al.. (2022). Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo.. Journal of Clinical Oncology. 40(4_suppl). 464–464. 1 indexed citations
12.
Blatt, Roni, Mijal Munster, Anna Shteingauz, et al.. (2021). In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso. Frontiers in Oncology. 11. 670809–670809. 20 indexed citations
13.
Voloshin, Tali, Lilach Koren, Yaara Porat, et al.. (2021). EXTH-74. INCREASING CANCER CELL MEMBRANE PERMEABILITY THROUGH APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS). Neuro-Oncology. 23(Supplement_6). vi180–vi180. 1 indexed citations
14.
Haber, Adi, Sivan Friedman, Lior Lobel, et al.. (2017). L-glutamine Induces Expression of Listeria monocytogenes Virulence Genes. PLoS Pathogens. 13(1). e1006161–e1006161. 47 indexed citations
15.
Haber, Adi, et al.. (2013). Allosteric inhibitors of HMG-CoA reductase, the key enzyme involved in cholesterol biosynthesis. Chemical Communications. 49(93). 10917–10917. 10 indexed citations
16.
Haber, Adi, Itzchak Angel, Atif Mahammed, & Zeev Gross. (2013). Combating diabetes complications by 1-Fe, a corrole-based catalytic antioxidant. Journal of Diabetes and its Complications. 27(4). 316–321. 27 indexed citations
17.
Haber, Adi. (2012). Metallocorroles for Attenuation of Atherosclerosis. Springer theses. 3 indexed citations
18.
Haber, Adi, Michael Aviram, & Zeev Gross. (2010). Protecting the beneficial functionality of lipoproteins by 1-Fe, a corrole-based catalytic antioxidant. Chemical Science. 2(2). 295–302. 43 indexed citations
19.
Haber, Adi, Atif Mahammed, Bianca Fuhrman, et al.. (2008). Amphiphilic/Bipolar Metallocorroles That Catalyze the Decomposition of Reactive Oxygen and Nitrogen Species, Rescue Lipoproteins from Oxidative Damage, and Attenuate Atherosclerosis in Mice. Angewandte Chemie International Edition. 47(41). 7896–7900. 72 indexed citations
20.
Haber, Adi, Hasmik Agadjanian, Lali K. Medina‐Kauwe, & Zeev Gross. (2007). Corroles that bind with high affinity to both apo and holo transferrin. Journal of Inorganic Biochemistry. 102(3). 446–457. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Lampkins Breakdown of academic impact, for papers by Lei Hu Breakdown of academic impact, for papers by Chenxi Wang Breakdown of academic impact, for papers by Carmelo Drago Breakdown of academic impact, for papers by Peter J. Choi Breakdown of academic impact, for papers by Vu Le Breakdown of academic impact, for papers by Gayathri Ratnaswamy Breakdown of academic impact, for papers by Caterina Bernini Breakdown of academic impact, for papers by Xueyan Zhen Breakdown of academic impact, for papers by Nobuyuki Fukui
Rankless by CCL
2026